Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timil H Patel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|July 30, 2020
Targeted Therapies in Advanced Gastric CancerTimil H Patel, Michael Cecchini
Indian Journal of Surgical Oncology|June 5, 2013
The emergence of surgeon-controlled robotic surgery in urologic oncologyTimil H Patel, Paurush Babbar, Ashok K Hemal
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
Surgeon-controlled robotic partial nephrectomy for a rare renal epithelioid angiomyolipoma using near-infrared fluorescence imaging using indocyanine green dye: A case report and literature reviewTimil H Patel, S Joseph Sirintrapun, Ashok K Hemal
The Lancet. Oncology|January 5, 2024
When less is more-reducing complexity in cancer trialsTimil H Patel, Donna R Rivera, Harpreet Singh, et al.
Leukemia Research|February 10, 2020
Disseminated, yet dissembled: Rare infections behind the veil of classical hairy cell leukemiaRory M Shallis, Timil H Patel, Nikolai A Podoltsev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2025
Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19Timil H Patel, Amy Corneli, Pamela Balcazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2023
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular CarcinomaTimil H Patel, Jamie R Brewer, Jiaxin Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other RearrangementTimil H Patel, Leigh Marcus, M Naomi Horiba, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|July 30, 2020
Targeted Therapies in Advanced Gastric CancerTimil H Patel, Michael Cecchini
Indian Journal of Surgical Oncology|June 5, 2013
The emergence of surgeon-controlled robotic surgery in urologic oncologyTimil H Patel, Paurush Babbar, Ashok K Hemal
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
Surgeon-controlled robotic partial nephrectomy for a rare renal epithelioid angiomyolipoma using near-infrared fluorescence imaging using indocyanine green dye: A case report and literature reviewTimil H Patel, S Joseph Sirintrapun, Ashok K Hemal
The Lancet. Oncology|January 5, 2024
When less is more-reducing complexity in cancer trialsTimil H Patel, Donna R Rivera, Harpreet Singh, et al.
Leukemia Research|February 10, 2020
Disseminated, yet dissembled: Rare infections behind the veil of classical hairy cell leukemiaRory M Shallis, Timil H Patel, Nikolai A Podoltsev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2025
Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19Timil H Patel, Amy Corneli, Pamela Balcazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2023
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular CarcinomaTimil H Patel, Jamie R Brewer, Jiaxin Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other RearrangementTimil H Patel, Leigh Marcus, M Naomi Horiba, et al.
Pageof 1